Eli Lilly gets FDA nod for additional doses of Trulicity to treat type 2 diabetes

This article was originally published here

The FDA approval, which enables to expand the label of once-weekly Trulicity to include 3.0mg and 4.5mg doses, was based on data from the AWARD-11 phase 3 trial,

The post Eli Lilly gets FDA nod for additional doses of Trulicity to treat type 2 diabetes appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply